期刊文献+

消瘿汤联用甲硫咪唑治疗高原地区甲状腺功能亢进临床研究 被引量:2

Clinical Study on Xiaoying Tang Combined with Methimazole for Hyperthyroidism in Plateau Area
原文传递
导出
摘要 目的:观察消瘿汤联合甲硫咪唑治疗高原地区甲状腺功能亢进(HPY)的临床疗效及其对患者甲状腺激素水平的影响。方法:将HPY患者80例随机分为照组与治疗组,每组40例。对照组给予甲硫咪唑治疗,治疗组在对照组的基础上加用自拟消瘿汤治疗,共治疗8周。观察比较2组临床疗效,2组治疗前后血清总三碘甲腺原氨酸(TT3)、总甲状腺素(TT4)、游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素(TSH)及证候积分变化。结果:总有效率治疗组为97.50%,对照组为80.00%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组血清TT3、TT4、FT3、FT4均较治疗前降低(P<0.05),TSH水平较治疗前升高(P<0.05);且治疗组上述各项指标改善均较对照组更显著(P<0.05)。治疗后,2组中医证候积分均较治疗前明显下降(P<0.05),且治疗组证候积分明显低于对照组(P<0.05)。结论:消瘿汤联用甲硫咪唑治疗HPY临床疗效确切,可显著缓解了患者临床症状,有效调节甲状腺激素水平。 Objective: To observe the clinical effect of Xiaoying tang combined with methimazole for hyperthyroidism(HPY) in plateau area and its effect on the level of thyroid hormones. Methods:A total of 80 cases of HPY patients were randomly divided into the control group and the treatment group, 40 cases in each group. The control group was given methimazole,and the treatment group was additionally given self-made Xiaoying tang based on the treatment of the control group. Both groups were treated for eight weeks. The clinical effect,and the changes in the levels of total triiodothyronine(TT3),total thyroxine(TT4),free triiodothyronine(FT3),free thyroxine(FT4),thyroid stimulating hormone(TSH) in serum as well as syndrome scores before and after treatment were observed and compared between the two groups. Results:The total effective rate was 97.50% in the treatment group and 80.00% in the control group,the difference being significant(P<0.05). After treatment,when compared with those before treatment,the levels of TT3,TT4,FT3 and FT4 in serum in the two groups were decreased(P<0.05),and the levels of TSH were increased(P<0.05);the improvement of above each index in the treatment group was more significant than that in the control group(P<0.05). After treatment, Chinese medicine syndrome scores in the two groups were significantly decreased when compared with those before treatment(P<0.05),and syndrome scores in the treatment group were significantly lower than those in the control group(P<0.05). Conclusion:The therapy of Xiaoying tang combined with methimazole in treating HPY has definite clinical effect,which can significantly relieve patients’ clinical symptoms,effectively regulate the level of thyroid hormones.
作者 都增强 苏文博 邓晨 章立 DU Zengqiang;SU Wenbo;DENG Chen;ZHANG Li
出处 《新中医》 CAS 2020年第14期73-75,共3页 New Chinese Medicine
基金 青海省科技厅项目(26330588)。
关键词 甲状腺功能亢进 高原地区 消瘿汤 甲硫咪唑 甲状腺激素 Hyperthyroidism Plateau area Xiaoying tang Methimazole Thyroid hormones
  • 相关文献

参考文献7

二级参考文献64

  • 1周强,甄仲,刘超,王佳,仝小林.单味中药治疗甲状腺功能亢进的机制研究概况[J].辽宁中医杂志,2010,37(S1):343-345. 被引量:22
  • 2易宁育,夏宗勤,胡雅儿,吕志良,向荣.一些滋阴助阳药调整β肾上腺素受体cAMP系统及M胆碱受体cGMP系统间失平衡的分子机理[J].中药药理与临床,1994,10(6):10-12. 被引量:18
  • 3葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.259~265.
  • 4刘艳骄,魏军平,杨洪军.甲状腺疾病中西医结合治疗学[M].北京:科学技术文献出版社,2012:5.
  • 5陈澋珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:1261-1267.
  • 6Olen E, Klinck GH. Hyperthyroidism and thyroid cancer [J]. Arch Pathol, 1966, 81(6) :531-535.
  • 7Cappelli C, Braga M, De Martino E, et al. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy [J]. Surg Today, 2006, 36(2) :125-130.
  • 8Senyurek Giles Y, Tunca F, Boztepe H, et al. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma [J]. Surgery, 2008, 144(6) :1028-1036.
  • 9Vaiana R, Cappelli C, Perini P, et al. Hyperthyroidism and concurrent thyroid cancer [ J ]. Tumor, 1999, 85 (4) : 247-252.
  • 10Sundram F, Robinson BG, Kung A, et al. Well-differentiated epithelial thyroid cancer management in the Asia Pacific region a report and clinical guideline [ J ]. Thyroid, 2006, 16 (5) :461-469.

共引文献185

同被引文献25

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部